Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Control Groups × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 41 Pain, Postoperative 6 Motor Activity 4 Pain 3 Fatigue 3 Agnosia 3 Sleep Initiation and Maintenance Disorders 2 Parasomnias 2 Hot Flashes 2 Depression 2 Chronic Pain 2 Syndrome 1 Peripheral Nervous System Diseases 1 Patient Participation 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphedema 1 Lung Neoplasms 1 Health Education 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Self-Examination 1 Breast Cancer Survivors 1 Breast Cancer Female 1 Anxiety Disorders 1 Alzheimer Disease 1 Altitude Sickness 1 Acute Pain 1

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03250351 2023-08-25

PT-ND-BC

University of Alcala

Phase NA Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡